CoVPN | sciencenewsnet.in

Breaking News

Down on Vitamin D? It could be the cause of chronic inflammation

Smog increases the risk of adverse health effects in pregnant mothers and babies

Fancy a side of 3D printed carrots and crickets with your meal?

Researchers Identify Common Long COVID Symptoms and Potential Causes for The Condition

Making House Calls Guided by AI

New recommendations aim to ease patient access to lung cancer clinical trials

Researchers unveil key processes in marine microbial evolution

‘Simple yet powerful’: Seeing cell secretion like never before

MSU researchers show that locusts can ‘sniff’ out human cancer

Best New Dean of Skaggs School of Pharmacy and Pharmaceutical Science

08 Aug, 2022

CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

June 28, 2022 sarah JonasResearch Results

A new analysis of the Novavax PREVENT-19 clinical trial concluded that this recombinant protein vaccine produced an antibody response comparable to mRNA vaccines and, if authorized, could help bolster global vaccine supplies. This is the first study to directly support antibody correlates of protection for a recombinant protein COVID-19 vaccine.

CoVPN’s Faith and Diversity Work Engages Key Communities Impacted by COVID-19

March 11, 2021 sarah JonasAnnouncement

The COVID-19 Prevention Network (CoVPN) released today the CoVPN Faith Initiative and Diversity Report, which provides a snapshot of key work to build trust, inform and engage the communities hardest hit by the pandemic in conversations about faith, COVID-19 and CoVPN clinical trials.